According to the report published by Visiongain, In 2020, the worldwide business volume of aortic valve replacement systems is projected at USD 7.81 billion. A CAGR of 11.1 percent is expected to be posted over the forecast period 2020-2030. Growing incidence of valvular illnesses, such as aortic stenosis and aortic regurgitation, and growing desire for minimally invasive surgery are among the main factors in the development of the industry. It is also anticipated that initiatives conducted by different public organisations to raise consciousness of valve replacement surgery will increase market growth.
The aging population is a significant cause of development on the U.S. cardiac surgery industry. The frequency of heart failure will rise as the population grows. Moreover, older people are often unfit for open heart surgery. The aging population also fuels the development of minimally invasive processes, such as heart valve substitutes from transcatheters. In the industry for cardiac surgery, there is also an evolving tendency towards minimally invasive processes. Minimally invasive processes decrease pain and hospitalization relative to traditional open-heart surgery for the person.
TAVR technology has been making remarkable progress over the past 15 years, transforming a difficult action into a uniform, easy and simplified operation. The recent batch of TAVR systems integrated characteristics to decrease the shipping catheter image, facilitate implementation, and allow repositioning and recovery capacity to achieve the required stance and decrease problems associated with TAVR. Current TAVR systems can be split into balloon-expandable, self-expanding, and mechanically expandable classifications, depending on the sort of installation.
Severe symptomatic aortic stenosis (SA) is the most common valvar heart disease in older people and, if kept untreated, is linked with bad results. The traditional therapy is surgical aortic valve replacement (SAVR), which appears to enhance signs, performance of lives, and prolong survival. However, due to the various comorbidities they have, a significant amount of clients (30 percent –40 percent) is considered inappropriate for SAVR, which significantly raises the per behavioral danger. The effectiveness of a percutaneous valve implantation in a person with AS was first established in 2002, offering a successful less invasive option therapy for valvar heart disease. Since then, efforts have been produced to tackle the original constraints of the technology of variable catheter aortic pump substitute (TAVR) and expand its apps. New developments in valves and TAVR enabling devices have reduced the risk of complications, simplified the procedure and enabled the treatment of more complex anatomies, whereas evidence from registries and randomized control studies has provided robust data on the effectiveness of this therapy, which is now considered the treatment of choice in inoperable patients and selected high-risk populations.
Transcatheter aortic-valve substitution (TAVR) is quickly growing in individuals with serious symptomatic aortic stenosis (AS) with elevated danger of surgical valve replacement as an option to surgery. In 2002, the TAVR procedure was first performed in a patient and since then both the valves and the delivery systems have undergone substantial changes to improve their performance. Two TAVR systems are currently approved for the treatment of severe aortic stenosis by the Food and Drug Administration in the United States: the balloon-expandable Sapien XT valve (Edwards Lifesciences) and the self-expanding CoreValve (Medtronic, Inc.). The Sapien XT balloon expandable valve consists of three pericardial bovine flyers installed within a box of cobalt chrome. On a rocket shipping catheter, the tube is crimped and implemented by rocket inflation in the indigenous aortic annulus. The self-expanding CoreValve consists of a matrix of nitinol inside which is installed on three pericardial porcine flyers. This tube is packed into a catheter and implemented inside the indigenous aortic tube by unsheathing the nitinol stent.
Why you should buy Aortic Valve Replacement Devices Market Forecast 2020-2030: Forecasts and Analysis By Surgery (Open, Minimally Invasive), By Product (Transcatheter Aortic Valve, Sutureless Valve), By End-user and Geography, with Profiles of Leading Companies
What is the future of the Aortic Valve Replacement Devices market? Visiongain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.
We guarantee in this 175 page report you will receive the following key information –
– View Aortic Valve Replacement Devices market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
– Aortic Valve Replacement Devices revenue forecast
– Aortic Valve Replacement Devices connections forecast
– Examine 123 tables, charts, and graphs.
– Let our analysts present you with a thorough assessment of the current and future Aortic Valve Replacement Devices market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Aortic Valve Replacement Devices sector
– Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Aortic Valve Replacement Devices industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organisation can succeed. Avoid falling behind. Stay informed about the potential for each of these Aortic Valve Replacement Devices submarkets with individual forecasts and analysis from 2020-2030.
– Product submarket forecast 2020-2030
– Surgery submarket forecast 2020-2030
– End-Use submarket forecast 2020-2030
– Learn about the market prospects for the leading Aortic Valve Replacement Devices market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Aortic Valve Replacement Devices revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.
– Product Revenue Forecast 2020-2030
– Transcatheter aortic valve Market Forecast, 2020-2030
– Sutureless valve Market Forecast, 2020-2030
– Other Product Market Forecast, 2020-2030
– Surgery Revenue Forecast 2020-2030
– Open surgery Market Forecast, 2020-2030
– Minimally invasive surgery Market Forecast, 2020-2030
– Other Surgery Market Forecast, 2020-2030
– End-Use Revenue Forecast 2020-2030
– Hospitals Market Forecast, 2020-2030
– Ambulatory surgery centers Market Forecast, 2020-2030
– Other End-User Market Forecast, 2020-2030
– Understand the prospects for the 4 regional and the leading 12 national Aortic Valve Replacement Devices markets – where will the highest revenues and opportunities occur?
– Learn about the market potential for Aortic Valve Replacement Devices companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts
– North America Aortic Valve Replacement Devices revenue forecast 2020-2030
– US Aortic Valve Replacement Devices revenue forecast 2020-2030
– Canada Aortic Valve Replacement Devices revenue forecast 2020-2030
– Mexico Aortic Valve Replacement Devices revenue forecast 2020-2030
– North America Aortic Valve Replacement Devices by Product revenue forecast 2020-2030
– North America Aortic Valve Replacement Devices by Surgery revenue forecast 2020-2030
– North America Aortic Valve Replacement Devices by End-Use revenue forecast 2020-2030
– Asia Pacific Aortic Valve Replacement Devices revenue forecast 2020-2030
– China Aortic Valve Replacement Devices revenue forecast 2020-2030
– Japan Aortic Valve Replacement Devices revenue forecast 2020-2030
– India Aortic Valve Replacement Devices revenue forecast 2020-2030
– Australia Aortic Valve Replacement Devices revenue forecast 2020-2030
– Rest of Asia Pacific Aortic Valve Replacement Devices revenue forecast 2020-2030
– Asia Pacific Aortic Valve Replacement Devices by Product revenue forecast 2020-2030
– Asia Pacific Aortic Valve Replacement Devices by Surgery revenue forecast 2020-2030
– Asia Pacific Aortic Valve Replacement Devices by End-Use revenue forecast 2020-2030
– European Aortic Valve Replacement Devices revenue forecast 2020-2030
– Germany Aortic Valve Replacement Devices revenue forecast 2020-2030
– UK Aortic Valve Replacement Devices revenue forecast 2020-2030
– France Aortic Valve Replacement Devices revenue forecast 2020-2030
– Italy Aortic Valve Replacement Devices revenue forecast 2020-2030
– Spain Aortic Valve Replacement Devices revenue forecast 2020-2030
– Rest of Europe Aortic Valve Replacement Devices revenue forecast 2020-2030
– European Aortic Valve Replacement Devices by Product revenue forecast 2020-2030
– European Aortic Valve Replacement Devices by Surgery revenue forecast 2020-2030
– European Aortic Valve Replacement Devices by End-Use revenue forecast 2020-2030
– Rest of World Aortic Valve Replacement Devices revenue forecast 2020-2030
– Rest of World Aortic Valve Replacement Devices by Product revenue forecast 2020-2030
– Rest of World Aortic Valve Replacement Devices by Surgery revenue forecast 2020-2030
– Rest of World Aortic Valve Replacement Devices by End-Use revenue forecast 2020-2030
– Explore the factors affecting Aortic Valve Replacement Devices product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialisation by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry
– Identify who the leading companies are in the Aortic Valve Replacement Devices industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Aortic Valve Replacement Devices companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.
Leading Companies in the Global Aortic Valve Replacement Devices Market
Edward Lifesciences Corporation
Boston Scientific Corporation
Symetis SA
St. Jude Medical (Abbott)
Medtronic
LivaNova PLC. (Sorin Group)
Maquet
Abiomed
HeartWare Inc.
Admedes Schuessler GmbH
Discover Information found nowhere else in this independent assessment of the Aortic Valve Replacement Devices market
The Aortic Valve Replacement Devices Market Forecast 2020-2030: Forecasts and Analysis By Product, By Surgery, By End-Use and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Aortic Valve Replacement Devices sector analysis. With the independent business intelligence found only in our work, you will discover where the prospects are for profit. In particular, our new research provides you with key strategic advantages: Our informed forecasts, independent and objective analysis, exclusive interviews and revealing company profiles will provide you with that necessary edge, allowing you to gain ground over your competitors.
With this report you are less likely to fall behind in knowledge or miss crucial business opportunities. You will save time and receive recognition for your market insight. See how you this report could benefit and enhance your research, analysis, company presentations and ultimately your individual business decisions and your company’s prospects.
What makes this report unique?
Visiongain’s research methodology involves an exclusive blend of primary and secondary sources providing informed analysis. This methodology allows insight into the key drivers and restraints behind market dynamics and competitive developments. The report therefore presents an ideal balance of qualitative analysis combined with extensive quantitative data including global, submarket and regional markets forecasts from 2020-2030
How the Aortic Valve Replacement Devices Market Forecast 2020-2030: Forecasts and Analysis By Product, By Surgery, By End-Use and and Geography, with Profiles of Leading Companies report can benefit you
Visiongain’s report is for anyone requiring analysis of the Aortic Valve Replacement Devices market. You will discover market forecasts, technological trends, predictions and expert opinion providing you with independent analysis derived from our extensive primary and secondary research. Only by purchasing this report will you receive this critical business intelligence revealing where revenue growth is likely and where the lucrative potential market prospects are. Don’t miss this key opportunity to gain a competitive advantage.
Avoid falling behind your competitors, overlooking critical business opportunities or losing industry influence. In our new report you will discover forecasts from 2020-2030 at the global, submarket, and national level. The report also assesses technologies, competitive forces and expected product pipeline developments. Read on to discover the prospects for the Aortic Valve Replacement Devices sector and find out what its future market prospects are.
If you buy our report today your knowledge will stay one step ahead of your competitors. Discover how our report could benefit your research, analyses and strategic decisions, saving you time. To gain an understanding of how to tap into the potential of this market and stay one step ahead of the competition you must order now our report the Aortic Valve Replacement Devices Market Forecast 2020-2030: Forecasts and Analysis By Product, By Surgery, By End-Use and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Aortic Valve Replacement Devices sector analysis. Avoid missing out – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Report Overview
1.1 Global Aortic Valve Replacement Devices Market Definition
1.2 Global Aortic Valve Replacement Devices Market Overview
1.3 Global Aortic Valve Replacement Devices Market Segmentation
1.4 Research Scope of Aortic Valve Replacement Devices in the Industry
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Methodology
1.8.1 Secondary Research
1.8.2 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Aortic Valve Replacement Devices Systems Market
2.1 Market Definition
2.2 Industry Structure
2.3 Industry Outlook
2.4 Current Status & Trends
2.4.1 Initiatives for creating awareness of valve replacement
2.4.2 Increasing preference for minimally invasive surgeries
2.4.3 Product recalls owing to the safety concern
2.4.4 Rising prevalence of valvular diseases
2.5 Product Penetration & growth prospect Analysis
2.5.1 Advanced manufacturing process innovation
3. Global Aortic Valve Replacement Devices Market Analysis
3.1 PEST Analysis of the Aortic Valve Replacement Devices Market
3.2 Expert Opinion
3.2.1 Primary Correspondents
3.3 Market Outlook
3.4 Drivers & Restraints
3.5 Dominant Region/Country
3.6 Market Scenario
3.7 Overall Growth Rate, Globally
3.8 SWOT Analysis of the Aortic Valve Replacement Devices Market
3.8.1 Strengths
3.8.2 Weaknesses
3.8.3 Opportunities
3.8.4 Threats
3.9 Porter’s Five Forces Analysis
3.9.1 Competitive Rivalry
3.9.1.1 Powerful Competitive Strategy
3.9.1.2 Firm Concentration Ratio
3.9.1.3 Degree Of Transparency
3.9.2 Supplier Power
3.9.2.1 Supplier Switching Costs Relative To Firm Switching Costs
3.9.2.2 Supplier Concentration To Firm Concentration Ratio
3.9.2.3 Degree Of Differentiation Of Inputs
3.9.3 Buyer Power
3.9.3.1 Degree Of Dependency Upon Existing Channels Of Distribution
3.9.3.2 Buyer Switching Costs Relative To Firm Switching Costs
3.9.3.3 Buyer Concentration To Firm Concentration Ratio
3.9.4 Threat Of Substitute
3.9.4.1 Buyer Propensity To Substitute
3.9.4.2 Relative Price Performance Of Substitute
3.9.4.3 Perceived Level Of Product Differentiation
3..9.5 Threat Of New Entrant
3.9.5.1 Economies Of Scale
3.9.5.2 Switching Costs Or Sunk Costs
3.9.5.3 Industry Profitability (Market CAGR)
4. Aortic Valve Replacement Devices: Global Market Analysis by Segments
4.1 Global Aortic Valve Replacement Devices Market Forecast, by Product 2020-2030
4.1.1 Product Overview
4.1.2 Transcatheter aortic valve Market Forecast, 2020-2030
4.1.3 Sutureless valve Market Forecast, 2020-2030
4.1.4 Other Product Market Forecast, 2020-2030
4.2 Global Aortic Valve Replacement Devices Market Forecast, by Surgery 2020-2030
4.2.1 Surgery Overview
4.2.2 Open surgery Market Forecast, 2020-2030
4.2.3 Minimally invasive surgery Market Forecast, 2020-2030
4.2.4 Other Surgery Market Forecast, 2020-2030
4.3 Global Aortic Valve Replacement Devices Market Forecast, by End-User 2020-2030
4.3.1 End-User Overview
4.3.2 Hospitals Market Forecast, 2020-2030
4.3.3 Ambulatory surgery centers Market Forecast, 2020-2030
4.3.4 Other End-User Market Forecast, 2020-2030
5. Leading Regions in Aortic Valve Replacement Devices Market 2020-2030
5.1 Regional Overview
5.1.1 North America
5.1.2 Europe
5.1.3 Asia Pacific
5.1.4 LAMEA
5.1.5 Leading Countries/ Regions
5.2 North America Aortic Valve Replacement Devices Market Forecast, 2020-2030
5.2.1 North America Aortic Valve Replacement Devices Submarket, By Product Forecast 2020-2030
5.2.2 North America Aortic Valve Replacement Devices Submarket, By Surgery Forecast 2020-2030
5.2.3 North America Aortic Valve Replacement Devices Submarket, By End-User Forecast 2020-2030
5.2.4 North America Aortic Valve Replacement Devices Submarket, By Country Forecast 2020-2030
5.2.4.1 U.S. Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.2.4.2 Canada Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.2.4.3 Mexico Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.3 Europe Aortic Valve Replacement Devices Market Forecast, 2020-2030
5.3.1 Europe Aortic Valve Replacement Devices Submarket, By Product Forecast 2020-2030
5.3.2 Europe Aortic Valve Replacement Devices Submarket, By Surgery Forecast 2020-2030
5.3.3 Europe Aortic Valve Replacement Devices Submarket, By End-User Forecast 2020-2030
5.3.4 Europe Aortic Valve Replacement Devices Submarket, By Country Forecast 2020-2030
5.3.4.1 U.K. Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.3.4.2 Germany Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.3.4.3 France Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.3.4.4 Italy Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.3.4.5 Spain Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.3.4.6 The Netherlands Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.3.4.7 Rest of Europe Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.4 Asia-Pacific Aortic Valve Replacement Devices Market Forecast, 2020-2030
5.4.1 Asia-Pacific Aortic Valve Replacement Devices Submarket, By Product Forecast 2020-2030
5.4.2 Asia-Pacific Aortic Valve Replacement Devices Submarket, By Surgery Forecast 2020-2030
5.4.3 Asia-Pacific Aortic Valve Replacement Devices Submarket, By End-User Forecast 2020-2030
5.4.4 Asia-Pacific Aortic Valve Replacement Devices Submarket, By Country Forecast 2020-2030
5.4.4.1 China Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.4.4.2 India Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.4.4.3 Japan Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.4.4.4 Korea Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.4.4.5 Indonesia Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.4.4.6 Australia Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.4.4.7 Rest of Asia-Pacific Aortic Valve Replacement Devices Market, Forecast 2020-2030
5.5 Rest of World Aortic Valve Replacement Devices Market Forecast, 2020-2030
5.5.1 Rest of World Aortic Valve Replacement Devices Submarket, By Product Forecast 2020-2030
5.5.2 Rest of World Aortic Valve Replacement Devices Submarket, By Surgery Forecast 2020-2030
5.5.3 Rest of World Aortic Valve Replacement Devices Submarket, By End-User Forecast 2020-2030
6. Leading Companies in The Aortic Valve Replacement Devices Market
6.1 Edward Lifesciences Corporation
6.1.1 Edward Lifesciences Corporation Overview
6.1.2 Analysis of Edward Lifesciences Corporation Products and Services
6.1.3 Edward Lifesciences Corporation Primary Market Competitors 2019
6.1.4 Edward Lifesciences Corporation Key Developments
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Company Overview
6.2.2 Analysis of Boston Scientific Corporation Products and Services
6.2.3 Boston Scientific Corporation Primary Market Competitors 2019
6.2.4 Boston Scientific Corporation Key Developments
6.3 Symetis SA
6.3.1 Symetis SA Company Overview
6.3.2 Analysis of Symetis SA Products and Services
6.3.3 Symetis SA Primary Market Competitors 2019
6.3.4 Symetis SA Key Developments
6.4 St. Jude Medical
6.4.1 St. Jude Medical Company Overview
6.4.2 Analysis of St. Jude Medical Products and Services
6.4.3 St. Jude Medical Primary Market Competitors 2019
6.4.4 St. Jude Medical Key Developments
6.5 Medtronic
6.5.1 Medtronic Company Overview
6.5.2 Analysis of Medtronic Products and Services
6.5.3 Medtronic Primary Market Competitors 2019
6.5.4 Medtronic Key Developments
6.6 LivaNova PLC.
6.6.1 LivaNova PLC. Company Overview
6.6.2 Analysis of LivaNova PLC. Products and Services
6.6.3 LivaNova PLC. Primary Market Competitors 2019
6.6.4 LivaNova PLC. Key Developments
6.7 Maquet
6.7.1 Maquet Company Overview
6.7.2 Analysis of Maquet Products and Services
6.7.3 Maquet Primary Market Competitors 2019
6.7.4 Maquet Key Developments
6.8 Abiomed
6.8.1 Abiomed Company Overview
6.8.2 Analysis of Abiomed Products and Services
6.8.3 Abiomed Primary Market Competitors 2019
6.8.4 Abiomed Key Developments
6.9 HeartWare Inc.
6.9.1 HeartWare Inc. Company Overview
6.9.2 Analysis of HeartWare Inc. Products and Services
6.9.3 HeartWare Inc. Primary Market Competitors 2019
6.9.4 HeartWare Inc. Key Developments
6.10 Admedes Schuessler GmbH
6.10.1 Admedes Schuessler GmbH Company Overview
6.10.2 Analysis of Admedes Schuessler GmbH Products and Services
6.10.3 Admedes Schuessler GmbH Primary Market Competitors 2019
6.10.4 Admedes Schuessler GmbH Key Developments
7. Conclusions and Recommendations
7.1. Key Research Findings
7.2. Conclusion by Geography
7.3. Conclusion by Solution Type
7.4. Strategic Recommendations
8. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form
List of Figures
Figure 1.1 Global Aortic Valve Replacement Devices Market Segmentation
Figure 2.1 Aortic Valve Replacement Devices Value Chain Analysis
Figure 3.1 Aortic Valve Replacement Devices Supply-Demand Analysis
Figure 4.1 Global Aortic Valve Replacement Devices Forecast 2020-2030 ($billion, AGR %)
Figure 4.2 Global Aortic Valve Replacement Devices Market Forecast 2020-2030
Figure 4.3 Global Aortic Valve Replacement Devices Submarket Forecast by 2020-2030 ($ billion)
Figure 4.4 Global Aortic Valve Replacement Devices Market By Product Share Forecast 2019, 2025, 2029 (% Share)
Figure 4.19 Global Aortic Valve Replacement Devices by Submarket By Product Forecast 2020-2030 ($ million)
Figure 4.20 Global Aortic Valve Replacement Devices Market, by Share Forecast 2019, 2025, 2029 (% Share)
Figure 4.21 Aortic Valve Replacement Devices Market, By Surgery Forecast 2020-2030 ($billion, AGR%)
Figure 4.23 Aortic Valve Replacement Devices Market, By End-User System Forecast 2020-2030 ($billion, AGR%)
Figure 4.25 Aortic Valve Replacement Devices Market, By Product Forecast 2020-2030 ($billion, AGR%)
Figure 4.27 Aortic Valve Replacement Devices Market, By Surgery Forecast 2020-2030 ($billion, AGR%)
Figure 5.1 Regional/Country Aortic Valve Replacement Devices Market, by 2020-2030
Figure 5.3 Leading Country/Regional Aortic Valve Replacement Devices Market Share, by 2020
Figure 5.4 Leading Country/Regional Aortic Valve Replacement Devices Market Share, by 2025
Figure 5.5 Leading Country/Regional Aortic Valve Replacement Devices Market Share, by 2030
Figure 5.6 Europe Aortic Valve Replacement Devices Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.7 Europe Aortic Valve Replacement Devices Market, by Forecast 2020-2030
Figure 5.8 Europe Aortic Valve Replacement Devices Submarket, By Product Forecast 2020-2030
Figure 5.9 Europe Aortic Valve Replacement Devices Submarket , By Surgery Forecast 2020-2030
Figure 5.10 Europe Aortic Valve Replacement Devices Submarket , By Country Forecast 2020-2030
Figure 5.11 Europe Aortic Valve Replacement Devices Submarket , By End-User 2020-2030 ($billion, AGR%)
Figure 5.10 North America Aortic Valve Replacement Devices Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.11 North America Aortic Valve Replacement Devices Market, by Forecast 2020-2030
Figure 5.12 North America Aortic Valve Replacement Devices Submarket, By Product Forecast 2020-2030
Figure 5.13 North America Aortic Valve Replacement Devices Submarket , By Surgery Forecast 2020-2030
Figure 5.14 North America Aortic Valve Replacement Devices Submarket , By End-User Forecast 2020-2030
Figure 5.13 North America Aortic Valve Replacement Devices Submarket , By Country Forecast 2020-2030
Figure 5.14 Asia-Pacific Aortic Valve Replacement Devices Market Forecast 2020-2030 ($billion , AGR%)
Figure 5.15 Asia-Pacific Aortic Valve Replacement Devices Market, by Forecast 2020-2030
Figure 5.16 Asia-Pacific Aortic Valve Replacement Devices Submarket, By Product Forecast 2020-2030
Figure 5.17 Asia-Pacific Aortic Valve Replacement Devices Submarket , By Country Forecast 2020-2030
Figure 5.17 Asia-Pacific Aortic Valve Replacement Devices Submarket , By End-User Forecast 2020-2030
Figure 5.18 Rest of World Aortic Valve Replacement Devices Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.19 Rest of World Aortic Valve Replacement Devices Market, by Forecast 2020-2030
Figure 5.20 Rest of World Aortic Valve Replacement Devices Submarket, By Product Forecast 2020-2030
Figure 5.21 Rest of World Aortic Valve Replacement Devices Submarket , By Surgery Forecast 2020-2030
Figure 5.21 Rest of World Aortic Valve Replacement Devices Submarket , By End-User Forecast 2020-2030
Figure 6.1 3M Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.2 Boston Scientific Corporation Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.3 Symetis SA Total Company Sales 2013-2019 (US$ Bn, AGR %)
Figure 6.6 St. Jude Medical Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.7 St. Jude Medical Revenue % Share, by End-User Segment, 2019
Figure 6.8 St. Jude Medical Revenue % Share, by Geographical Trade, 2019
Figure 6.9 St. Jude Medical Revenue % Share, by Business Segment, 2019
Figure 6.10 Medtronic Revenue % Share, by Geographic Segment, 2019
Figure 6.11 LivaNova PLC. Company Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.12 Maquet Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.13 Maquet Revenue % Share, by Regional Segment, 2019
Figure 6.14 Abiomed Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.15 Abiomed Revenue % Share, by Regional Segment, 2019
Figure 6.16 Abiomed Revenue % Share, by Business Segment, 2019
Figure 6.17 HeartWare Inc. Total Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.18 Admedes Schuessler GmbH Total Company Revenue 2013-2019 (US$ bn, AGR %)
Figure 6.19 Admedes Schuessler GmbH Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.20 Admedes Schuessler GmbH Revenue % Share, by Business Segment, 2019
List of Tables
Table 1.0 Research Scope
Table 4.1 Global Aortic Valve Replacement Devices Market Forecast 2020-2030 ($Bn, AGR %, CAGR %)
Table 4.2 Global Aortic Valve Replacement Devices Submarket, By Product Forecast 2020-2030 ($billion, AGR %)
Table 4.3 Global Aortic Valve Replacement Devices Submarket, By End-User Forecast 2020-2030 ($billion, AGR %)
Table 5.1 Global Aortic Valve Replacement Devices Market, by Country/Region Forecast 2020-2030 ($billion, AGR %)
Table 5.3 Europe Aortic Valve Replacement Devices Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.4 Europe Aortic Valve Replacement Devices Submarket, By Product Forecast 2020-2030 ($billion, AGR %)
Table 5.5 Europe Aortic Valve Replacement Devices Submarket, By Surgery Forecast 2020-2030 ($billion, AGR %)
Table 5.6 North America Aortic Valve Replacement Devices Market Submarket, By End-User Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.7 North America Aortic Valve Replacement Devices Submarket, By Product Forecast 2020-2030 ($billion, AGR %)
Table 5.8 North America Aortic Valve Replacement Devices Submarket, By Surgery Forecast 2020-2030 ($billion, AGR %)
Table 5.9 Asia-Pacific Aortic Valve Replacement Devices Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.10 Asia-Pacific Aortic Valve Replacement Devices Submarket, By Product Forecast 2020-2030 ($billion, AGR %)
Table 5.11 Asia-Pacific Aortic Valve Replacement Devices Submarket, By Surgery Forecast 2020-2030 ($billion, AGR %)
Table 5.12 Rest of World Aortic Valve Replacement Devices Market Submarket, By End-User Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.13 Rest of World Aortic Valve Replacement Devices Submarket, By Product Forecast 2020-2030 ($billion, AGR %)
Table 5.14 Rest of World Aortic Valve Replacement Devices Submarket, By Surgery Forecast 2020-2030 ($billion, AGR %)
Table 6.1 3M Profile 2019 (Market Entry, Public/Private, Headquarters, Geography, Key Market, Listed on, Products/Services
Table 6.2 3M Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.3 3M Products and Services (Product/Service, Segment)
Table 6.4 3M Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.5 3M Total Company Recent Development 2015-2019
Table 6.6 Boston Scientific Corporation Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.7 Boston Scientific Corporation Products and Services (Product/Service, Segment)
Table 6.8 Boston Scientific Corporation Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.9 Boston Scientific Corporation Total Company Recent Development 2015-2019
Table 6.10 Symetis SA Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.11 Symetis SA Products and Services (Product/Service, Segment)
Table 6.12 Symetis SA Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.13 Symetis SA Total Company Recent Development 2015-2019
Table 6.14 St. Jude Medical Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.15 St. Jude Medical Products and Services (Product/Service, Segment)
Table 6.16 St. Jude Medical Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.17 St. Jude Medical Total Company Recent Development 2015-2019
Table 6.18 Medtronic Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.19 Medtronic Products and Services (Product/Service, Segment)
Table 6.20 Medtronic Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.21 Medtronic Total Company Recent Development 2015-2019
Table 6.22 LivaNova PLC. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.23 LivaNova PLC. Products and Services (Product/Service, Segment)
Table 6.24 LivaNova PLC. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.25 LivaNova PLC. Total Company Recent Development 2015-2019
Table 6.26 Maquet Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.27 Maquet Products and Services (Product/Service, Segment)
Table 6.28 Maquet Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.29 Maquet Total Company Recent Development 2015-2019
Table 6.30 Abiomed Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.31 Abiomed Products and Services (Product/Service, Segment)
Table 6.32 Abiomed Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.33 Abiomed Total Company Recent Development 2015-2019
Table 6.34 HeartWare Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.35 HeartWare Inc. Products and Services (Product/Service, Segment)
Table 6.36 HeartWare Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.37 HeartWare Inc. Total Company Recent Development 2015-2019
Table 6.38 Admedes Schuessler GmbH Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.39 Admedes Schuessler GmbH Products and Services (Product/Service, Segment)
Table 6.40 Admedes Schuessler GmbH Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.41 Admedes Schuessler GmbH Total Company Recent Development 2015-2019
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
